TrialCardiovascular diabetology2015

Effect of empagliflozin monotherapy on postprandial glucose and 24-hour glucose variability in Japanese patients with type 2 diabetes mellitus: a randomized, double-blind, placebo-controlled, 4-week study.

Rimei Nishimura et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.